Japan Intellectual Property Rights: USE OF IL-17 ANTAGONISTS FOR INHIBITING PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PATIENTS

Japan, Aug. 31 -- NOVARTIS AG has got intellectual property rights for 'USE OF IL-17 ANTAGONISTS FOR INHIBITING PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PATIENTS.' Other related details are as follows:

Application Number: JP,2024-199491

Category (FI): A61P17/06,C12N15/13,A61K31/519,A61K39/395@D,A61K45/00,A61K39/395@U,A61P19/08,A61P29/00,A61P43/00,111,A61P43/00,121,A61K45/06,C07K16/24,A61P19/02

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Nov. 15, 2024

Publication Date: Feb. 19, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.